Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration.

25 years of epidermal stem cell research. J Invest Dermatol (2011) 1.70

PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc Natl Acad Sci U S A (2011) 1.38

The mouse excisional wound splinting model, including applications for stem cell transplantation. Nat Protoc (2013) 1.32

Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One (2011) 1.30

Tracking the elusive fibrocyte: identification and characterization of collagen-producing hematopoietic lineage cells during murine wound healing. Stem Cells (2014) 1.19

Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities. PLoS One (2012) 1.11

Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res Ther (2013) 1.09

Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healing. Blood (2011) 1.06

To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells. Oncotarget (2013) 1.05

The effects of topical mesenchymal stem cell transplantation in canine experimental cutaneous wounds. Vet Dermatol (2013) 1.03

Differential response of human adipose tissue-derived mesenchymal stem cells, dermal fibroblasts, and keratinocytes to burn wound exudates: potential role of skin-specific chemokine CCL27. Tissue Eng Part A (2013) 1.01

Stem cell therapy: a novel & futuristic treatment modality for disaster injuries. Indian J Med Res (2012) 1.00

VEGF-mediated proliferation of human adipose tissue-derived stem cells. PLoS One (2013) 0.92

Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors. Cancer Res (2011) 0.91

Cell-based therapies for diabetic complications. Exp Diabetes Res (2011) 0.90

Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells Int (2010) 0.90

Mesenchymal Stem Cells Home to Sites of Injury and Inflammation. Adv Wound Care (New Rochelle) (2012) 0.89

Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression. Int J Mol Sci (2015) 0.89

Biochemistry of epidermal stem cells. Biochim Biophys Acta (2012) 0.88

Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft. J Immunol (2015) 0.88

In vivo multimodal microscopy for detecting bone-marrow-derived cell contribution to skin regeneration. J Biophotonics (2013) 0.86

A novel autologous cell-based therapy to promote diabetic wound healing. Ann Surg (2012) 0.85

Alteration of skin properties with autologous dermal fibroblasts. Int J Mol Sci (2014) 0.85

Characteristics and neural-like differentiation of mesenchymal stem cells derived from foetal porcine bone marrow. Biosci Rep (2013) 0.85

Sensitivity and dose dependency of radiation-induced injury in hematopoietic stem/progenitor cells in mice. Sci Rep (2015) 0.85

Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healing in diabetic rats. J Diabetes Res (2013) 0.84

Role of whole bone marrow, whole bone marrow cultured cells, and mesenchymal stem cells in chronic wound healing. Stem Cell Res Ther (2015) 0.84

Diabetic impairment of C-kit bone marrow stem cells involves the disorders of inflammatory factors, cell adhesion and extracellular matrix molecules. PLoS One (2011) 0.84

Detection of endothelial progenitor cells in human skin wounds and its application for wound age determination. Int J Legal Med (2015) 0.84

Advances in understanding and treating dystrophic epidermolysis bullosa. F1000Prime Rep (2014) 0.83

Three-dimensional spheroid-cultured mesenchymal stem cells devoid of embolism attenuate brain stroke injury after intra-arterial injection. Stem Cells Dev (2014) 0.83

Tumor Vessel Development and Expansion in Ewing's Sarcoma: A Review of the Vasculogenesis Process and Clinical Trials with Vascular-Targeting Agents. Sarcoma (2011) 0.82

Targeting lysophosphatidic acid signaling retards culture-associated senescence of human marrow stromal cells. PLoS One (2012) 0.82

A method to generate enhanced GFP+ chimeric mice to study the role of bone marrow-derived cells in the eye. Exp Eye Res (2013) 0.81

A novel method for efficient delivery of stem cells to the ischemic brain. Stem Cell Res Ther (2013) 0.81

The mobilization and recruitment of c-kit+ cells contribute to wound healing after surgery. PLoS One (2012) 0.79

Estrogen deficiency heterogeneously affects tissue specific stem cells in mice. Sci Rep (2015) 0.79

Dopamine regulates mobilization of mesenchymal stem cells during wound angiogenesis. PLoS One (2012) 0.79

Hypertrophic scarring: the greatest unmet challenge after burn injury. Lancet (2016) 0.78

In vitro migration and proliferation ("wound healing") potential of mesenchymal stromal cells generated from human CD271(+) bone marrow mononuclear cells. J Transl Med (2015) 0.78

Immunohistological localization of endogenous unlabeled stem cells in wounded skin. J Histochem Cytochem (2014) 0.78

Mobilization of CD34+-progenitor cells in patients with severe trauma. PLoS One (2014) 0.78

Insight into Reepithelialization: How Do Mesenchymal Stem Cells Perform? Stem Cells Int (2015) 0.78

Regenerative Potential of Mesenchymal Stromal Cells: Age-Related Changes. Stem Cells Int (2016) 0.77

Novel in vitro culture condition improves the stemness of human dermal stem/progenitor cells. Mol Cells (2013) 0.76

The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks. J Oncol (2011) 0.76

Advances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future Perspectives. Int J Mol Sci (2017) 0.75

Basic Fibroblast Growth Factor Stimulates the Proliferation of Bone Marrow Mesenchymal Stem Cells in Giant Panda (Ailuropoda melanoleuca). PLoS One (2015) 0.75

New approach of bone marrow-derived mesenchymal stem cells and human amniotic epithelial cells applications in accelerating wound healing of irradiated albino rats. Int J Stem Cells (2013) 0.75

Enhancement of Bone-Marrow-Derived Mesenchymal Stem Cell Angiogenic Capacity by NPWT for a Combinatorial Therapy to Promote Wound Healing with Large Defect. Biomed Res Int (2017) 0.75

Cinnamtannin B-1 Promotes Migration of Mesenchymal Stem Cells and Accelerates Wound Healing in Mice. PLoS One (2015) 0.75

Periodontal regeneration in swine after cell injection and cell sheet transplantation of human dental pulp stem cells following good manufacturing practice. Stem Cell Res Ther (2016) 0.75

Bone marrow mesenchymal stem cell aggregate: an optimal cell therapy for full-layer cutaneous wound vascularization and regeneration. Sci Rep (2015) 0.75

Cells from the hematopoietic lineage are only present transiently during healing in a mouse model of non-severe burn injury. Stem Cell Res Ther (2015) 0.75

Bone Marrow-derived Cell Therapy for Oral Mucosal Repair after Irradiation. J Dent Res (2014) 0.75

Autologous mesenchymal stem cells applied on the pressure ulcers had produced a surprising outcome in a severe case of neuromyelitis optica. Neural Regen Res (2015) 0.75

Potential of bone marrow mesenchymal stem cells in rejuvenation of the aged skin of rats. Biomed Rep (2017) 0.75

From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa. Mol Ther (2015) 0.75

Trichostatin A stabilizes the expression of pluripotent genes in human mesenchymal stem cells during ex vivo expansion. PLoS One (2013) 0.75

Hematopoietic progenitors are required for proper development of coronary vasculature. J Mol Cell Cardiol (2015) 0.75

Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19

Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27

Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24

Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 20.65

Cutaneous wound healing. N Engl J Med (1999) 19.12

Marrow stromal cells as stem cells for nonhematopoietic tissues. Science (1997) 17.06

Wound healing--aiming for perfect skin regeneration. Science (1997) 16.08

Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med (2005) 12.03

Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med (2000) 11.35

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36

Endothelial progenitor cells: characterization and role in vascular biology. Circ Res (2004) 7.91

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest (2004) 7.91

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (2007) 7.57

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A (2003) 7.41

Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol (2001) 7.40

Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation (2003) 7.29

Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med (1994) 7.19

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med (2003) 7.14

Haematopoietic stem cell release is regulated by circadian oscillations. Nature (2008) 6.50

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation (2004) 6.43

Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res (2004) 6.34

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A (2005) 6.16

Evidence for circulating bone marrow-derived endothelial cells. Blood (1998) 6.15

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One (2008) 5.91

Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells (2007) 5.83

Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation (2002) 5.82

Wound healing and its impairment in the diabetic foot. Lancet (2005) 5.63

Why are MSCs therapeutic? New data: new insight. J Pathol (2009) 5.25

Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med (2004) 4.59

Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol (2005) 4.53

Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation (2005) 4.49

Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes (2004) 4.24

CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res (2005) 4.14

Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol (2008) 4.07

Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol (2008) 3.67

Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest (2007) 3.63

Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen (2004) 3.60

Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood (1980) 3.51

Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum (2003) 3.39

Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol (2004) 3.34

Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res (2001) 3.30

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation (2004) 3.26

Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res (2009) 3.25

Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med (2000) 3.25

The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest (2007) 3.15

Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells (2004) 3.15

Lack of a fusion requirement for development of bone marrow-derived epithelia. Science (2004) 3.14

Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell (2008) 3.08

Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem (2004) 3.02

Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng (2007) 2.92

Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells (2004) 2.88

Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood (2004) 2.72

Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells (2004) 2.70

Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol (2003) 2.65

Circulating skeletal stem cells. J Cell Biol (2001) 2.58

Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells (2003) 2.53

Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res (2004) 2.49

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood (2002) 2.43

Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int (2005) 2.43

The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A (1997) 2.36

Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol (2001) 2.33

Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells (2005) 2.30

Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum (2002) 2.20

Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng (1999) 2.16

Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells (2006) 2.15

Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res (2002) 2.11

MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest (1998) 2.09

Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res (2002) 2.03

Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol (2003) 1.99

From stem cells to viable autologous semilunar heart valve. Circulation (2005) 1.94

Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men. J Appl Physiol (1985) (2006) 1.92

Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells (2007) 1.92

Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen (2007) 1.87

Promotion of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci U S A (1989) 1.82

Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res (1998) 1.81

Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation (2005) 1.75

Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci U S A (1989) 1.73

Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem (2005) 1.72

Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant (1997) 1.69

Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med (2009) 1.68

Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation (2001) 1.67

The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells (2003) 1.65

HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood (2005) 1.62

Angiogenesis in wound healing. Pharmacol Ther (1991) 1.62

Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen (2006) 1.58

Osteoclast precursors, RANKL/RANK, and immunology. Immunol Rev (2005) 1.57

Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant (2006) 1.55

Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen (2005) 1.52

Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell (2008) 1.49

Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells (2005) 1.46

Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells (2005) 1.46

Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity. J Immunol (2008) 1.45

Circulating mesenchymal stem cells. Int J Biochem Cell Biol (2004) 1.43

High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock (2006) 1.40

Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells (2005) 1.39

Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout. FASEB J (2006) 1.39

Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation (2007) 1.31

In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells (2005) 1.31

Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS One (2009) 1.31

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One (2008) 5.91

Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells (2007) 5.83

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev (2004) 2.30

Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest (2002) 2.05

Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol (2005) 1.88

Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen (2007) 1.87

Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen (2007) 1.56

Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons. Mol Cell Neurosci (2003) 1.55

Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen (2005) 1.52

Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil (2005) 1.47

Toxic shock syndrome in an adult burn patient. Burns (2007) 1.39

Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood (2008) 1.39

Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol (2011) 1.36

The mouse excisional wound splinting model, including applications for stem cell transplantation. Nat Protoc (2013) 1.32

Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS One (2009) 1.31

Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One (2011) 1.30

Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue. Tissue Eng (2005) 1.29

Bladder outlet obstruction: progression from inflammation to fibrosis. BJU Int (2010) 1.28

The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Rev (2012) 1.28

The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. Exp Hematol (2011) 1.25

Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest (2008) 1.22

Infection control in the burn unit. Burns (2010) 1.19

The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis. J Plast Reconstr Aesthet Surg (2008) 1.15

Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen (2007) 1.10

Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol (2004) 1.10

Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes. J Leukoc Biol (2007) 1.10

Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. J Invest Dermatol (2006) 1.09

miR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation. J Cell Biochem (2013) 1.09

Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol (2005) 1.07

Anti-inflammatory activity of nanocrystalline silver in a porcine contact dermatitis model. Nanomedicine (2008) 1.07

Anti-inflammatory activity of nanocrystalline silver-derived solutions in porcine contact dermatitis. J Inflamm (Lond) (2010) 1.07

Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp Hematol (2004) 1.02

Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood (2004) 1.02

Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors. Mol Cell Biochem (2005) 1.01

Transforming growth factor-beta and its effect on reepithelialization of partial-thickness ear wounds in transgenic mice. Wound Repair Regen (2005) 1.01

Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion. Exp Hematol (2012) 1.00

The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit. J Trauma (2007) 0.99

Development, characterization, and wound healing of the keratin 14 promoted transforming growth factor-beta1 transgenic mouse. Wound Repair Regen (2002) 0.99

Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process. Wound Repair Regen (2011) 0.98

The molecular mechanism of hypertrophic scar. J Cell Commun Signal (2013) 0.97

Improvement in postburn hypertrophic scar after treatment with IFN-alpha2b is associated with decreased fibrocytes. J Interferon Cytokine Res (2007) 0.97

Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor. J Invest Dermatol (2004) 0.96

Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation. J Invest Dermatol (2005) 0.95

Quality-of-life and outcome predictors following massive burn injury. Plast Reconstr Surg (2005) 0.95

Improved scar in postburn patients following interferon-alpha2b treatment is associated with decreased angiogenesis mediated by vascular endothelial cell growth factor. J Interferon Cytokine Res (2008) 0.93

Hypertrophic scar, wound contraction and hyper-hypopigmentation. J Burn Care Res (2007) 0.92

Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar. Wound Repair Regen (2011) 0.91

The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev (2014) 0.90

Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes. Tissue Eng Part A (2013) 0.90

Mesenchymal stem/stromal cells induce the generation of novel IL-10-dependent regulatory dendritic cells by SOCS3 activation. J Immunol (2012) 0.89

Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG). J Cell Biochem (2003) 0.89

Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring. J Burn Care Res (2012) 0.89

Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin. J Cell Biochem (2006) 0.89

Dermal fibroblasts from different layers of human skin are heterogeneous in expression of collagenase and types I and III procollagen mRNA. Wound Repair Regen (2004) 0.89

The use of laser Doppler imaging as a predictor of burn depth and hypertrophic scar postburn injury. J Burn Care Res (2012) 0.88

Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG). J Cell Physiol (2004) 0.88

Proliferation of peripheral blood mononuclear cells is suppressed by the indoleamine 2,3-dioxygenase expression of interferon-gamma-treated skin cells in a co-culture system. Wound Repair Regen (2003) 0.87

Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment. Hum Immunol (2004) 0.87

Dynamic signals for hair follicle development and regeneration. Stem Cells Dev (2011) 0.87

Scar and contracture: biological principles. Hand Clin (2009) 0.86

Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder. J Am Acad Dermatol (2002) 0.86

Review of burn injuries secondary to home oxygen. J Burn Care Res (2012) 0.86

Deep dermal fibroblasts refractory to migration and decorin-induced apoptosis contribute to hypertrophic scarring. J Burn Care Res (2012) 0.86

Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-κB signaling. Exp Hematol (2010) 0.86

Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar. Biomaterials (2011) 0.86

Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia. Exp Biol Med (Maywood) (2012) 0.86

Carotid rupture following electrical injury: a report of two cases. J Burn Care Res (2012) 0.84

Latent and active transforming growth factor beta1 released from genetically modified keratinocytes modulates extracellular matrix expression by dermal fibroblasts in a coculture system. J Invest Dermatol (2002) 0.84

Increased severity of bleomycin-induced skin fibrosis in mice with leukocyte-specific protein 1 deficiency. J Invest Dermatol (2008) 0.84

A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar. Wound Repair Regen (2012) 0.84

Superficial dermal fibroblasts enhance basement membrane and epidermal barrier formation in tissue-engineered skin: implications for treatment of skin basement membrane disorders. Tissue Eng Part A (2013) 0.84

Three-dimensional spheroid-cultured mesenchymal stem cells devoid of embolism attenuate brain stroke injury after intra-arterial injection. Stem Cells Dev (2014) 0.83

Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS). Wound Repair Regen (2011) 0.83

Characterization of heterotopic ossification in burn patients. J Burn Care Res (2014) 0.82

Alterations in lymphocyte function and relation to phospholipid composition after burn injury in humans. Crit Care Med (2002) 0.82

Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen (2007) 0.81

Deep dermal fibroblast profibrotic characteristics are enhanced by bone marrow-derived mesenchymal stem cells. Wound Repair Regen (2013) 0.81

Differential expression of class I small leucine-rich proteoglycans in an animal model of partial bladder outlet obstruction. J Urol (2012) 0.81

Cell proliferating effect of latent transforming growth factor-beta1 is cell membrane dependent. Wound Repair Regen (2002) 0.81

Expression of a releasable form of annexin II by human keratinocytes. J Cell Biochem (2002) 0.81

Novel methods for the investigation of human hypertrophic scarring and other dermal fibrosis. Methods Mol Biol (2013) 0.80

Impaired cutaneous wound healing in transforming growth factor-β inducible early gene1 knockout mice. Wound Repair Regen (2012) 0.80

Does nanocrystalline silver have a transferable effect? Wound Repair Regen (2010) 0.79

The therapeutic potential of a C-X-C chemokine receptor type 4 (CXCR-4) antagonist on hypertrophic scarring in vivo. Wound Repair Regen (2014) 0.79

Fluorescent-activated cell-sorting analysis of intracellular interferon-gamma and interleukin-4 in fresh and frozen human peripheral blood T-helper cells. Wound Repair Regen (2005) 0.79

Pathophysiology and management of the burn scar. Clin Plast Surg (2009) 0.79

Complications of chlorine inhalation in a pediatric chemical burn patient: a case report. J Burn Care Res (2012) 0.79

Antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds in a fibrotic rabbit ear model. J Interferon Cytokine Res (2005) 0.78

The JCR:LA-cp rat: a novel model for impaired wound healing. Wound Repair Regen (2004) 0.78

The effect of treating infected skin grafts with Acticoat on immune cells. Burns (2006) 0.77

Serum Decorin, IL-1β, and TGF-β Predict Hypertrophic Scarring Postburn. J Burn Care Res (2015) 0.76

Fibrocytes participate in the development of heterotopic ossification. J Burn Care Res (2015) 0.76

Blunt carotid artery injury after minor facial trauma. Can J Plast Surg (2012) 0.75

Insulin suppresses collagenase stimulatory effect of stratifin in dermal fibroblasts. Mol Cell Biochem (2004) 0.75

Burn injury induces an inhibitory signal in the lung Smad pathway. Cytokine (2004) 0.75

Modified Meek Micrografting Technique for Wound Coverage in Extensive Burn Injuries. J Burn Care Res (2016) 0.75

Important Developments in Burn Care. Plast Reconstr Surg (2017) 0.75

Orthostatic convulsive syncope in a burn patient. J Burn Care Res (2012) 0.75

Strategies to increase flap survival in nasal reconstruction in patients with deep panfacial burns. J Burn Care Res (2013) 0.75

Serum Decorin, Interleukin-1β, and Transforming Growth Factor-β Predict Hypertrophic Scarring Postburn. J Burn Care Res (2016) 0.75